In the initial stage of cerebral ischemia, phosphorylated JNK induces NF-κB activation, which causes the production of excessive amounts of pro-inflammatory mediators in the ischemic area, subsequently exacerbating cerebral infarction. Here, NFKB1 is linked to brain infarction.